Tempest Therapeutics (3OS0.MU) Q2 2026 Earnings

14MayConfirmed
Q2 2026
-2.17
-1.53
-0.88
-0.24

Details

Expected EPS
-0.240044
Actual EPS
-2.1689689999999997
Surprise EPS
-1.93
Surprise Percent
+803.57%

Description

Tempest Therapeutics (3OS0.MU) has reported earnings of -2.1689689999999997 per share for Q2 2026.

0 Comments

Share your thoughts